Upregulation of HSP60 and ATF5 during UPRmt predominantly increases the carcinoma cell’s survival threshold and promotes tumor progression, therapeutic resistance, and resistance towards apoptosis [39, 83]. The gene discussed is ATF5; the disease is carcinoma.